Vice President, Cardiovascular & Metabolic Disease
Kiersten leads the overall US Cardiovascular & Metabolic Disease (US CVMD) team and is responsible for the strategic direction, selling strategy and performance of the cardiovascular and diabetes business units.
During her 15 years with AstraZeneca, Kiersten has served in various roles across many areas of the business, both in the US and globally, starting in supply chain and commercial operations. She has held marketing leadership roles for BRILINTA, CRESTOR, and EPANOVA and has held sales leadership roles in the both the Respiratory and Diabetes organizations. Most recently, Kiersten was Global Vice President, roxadustat, where she was responsible for setting the global strategy for the launch and commercialization of roxadustat, including working to support regions and key markets in setting and executing launch strategies.
- Bachelor of Science, Business Management and Marketing, Cornell University, Ithaca, New York
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.